Elvucitabine - AbsoluteAstronomy.com

Elvucitabine

Encyclopedia

Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Achillion Pharmaceuticals, Inc. for the treatment of HIV.

Currently, it is in Phase II clinical trials.

The source of this article is wikipedia, the free encyclopedia. The text of this article is licensed under the GFDL.